RTOG-0938
Terminated
Protocol Information
Tab containing protocol details, study design, and eligibility criteria
Tab containing study documents, informed consent forms, and study materials
Tab containing information for potential study participants
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Principal Investigator
Himu Lukka
Status
Terminated
Closed to Accrual
February 10, 2014
Closed to Accrual & Treatment
February 10, 2014
Closed to Accrual & Treatment
April 4, 2014
Complete
April 27, 2015
Terminated
May 20, 2022
Disease Site
Genitourinary [GU] Prostate
Phase
II
Developmental Therapeutics
No
Primary Objective
Data Collection Notice:
Data for this trial is being collected via the NRG/RTOG Data Center.
Patient Population
–
Target Accrual
240
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.
-
Share this study.
-
-
-
-
